Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP). - Turner N; Saura C; Aftimos P; van den Tweel E; Oesterholt M; Koper N; Colleoni M; Kaczmarek E; Punie K; Song X; Armstrong A; Bianchi G; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025)